Patents/Assignees

AELIX Therapeutics, S.L.

1 patent in portfolio

US11666651utility2023
Prime/boost Immunization Regimen Against HIV-1 Utilizing a Multiepitope T Cell Immunogen Comprising Gag, Pol, Vif, and Nef Epitopes
0 cites